EMEA-000885-PIP01-10

Key facts

Invented name
MicardisPlus
Active substance
  • telmisartan
  • hydrochlorothiazide
Therapeutic area
Cardiovascular diseases
Decision number
P/159/2010
PIP number
EMEA-000885-PIP01-10
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Boehringer Ingelheim International GmbH

Tel. +49 6132778271
E-mail: paediatrics@boehringer-ingelheim.com

 

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating